|
1
|
Lee RC, Feinbaum RL and Ambros V: The
C. elegans heterochronic gene lin-4 encodes small RNAs with
antisense complementarity to lin-14. Cell. 75:843–854. 1993.
|
|
2
|
Fire A, Xu S, Montgomery MK, Kostas SA,
Driver SE and Mello CC: Potent and specific genetic interference by
double-stranded RNA in Caenorhabditis elegans. Nature.
91:806–811. 1998. View
Article : Google Scholar
|
|
3
|
Silber J, Lim DA, Petritsch C, Persson AI,
Maunakea AK, Yu M, Vandenberg SR, Ginzinger DG, James CD, Costello
JF, Bergers G, Weiss WA, Alvarez-Buylla A and Hodgson JG: miR-124
and miR-137 inhibit proliferation of glioblastoma multiforme cells
and induce differentiation of brain tumor stem cells. BMC Med.
6:142008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Saito Y, Liang G, Egger G, Friedman JM,
Chuang JC, Coetzee GA and Jones PA: Specific activation of
microRNA-127 with downregulation of the proto-oncogene BCL6 by
chromatin-modifying drugs in human cancer cells. Cancer Cell.
9:435–443. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Coller HA, Forman JJ and Hegesse-Miller A:
Myc’ed messages: myc induces transcription of E2Fl while inhibiting
its translation via a microRNA polycistron. PLoS Genet.
3:e1462007.
|
|
6
|
He L, Thomson JM, Hemann MT,
Hernando-Monge E, Mu D, Goodson S, Powers S, Cordon-Cardo C, Lowe
SW, Hannon GJ and Hammond SM: A microRNA polycistron as a potential
human oncogene. Nature. 435:828–833. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Dews M, Homayouni A, Yu D, Murphy D,
Sevignani C, Wentzel E, Furth EE, Lee WM, Enders GH, Mendell JT and
Thomas-Tikhonenko A: Augmentation of tumor angiogenesis by a
Myc-activated microRNA cluster. Nat Genet. 38:1060–1065. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Karube Y, Tanaka H, Osada H, Tomida S,
Tatematsu Y, Yanagisawa K, Yatabe Y, Takamizawa J, Miyoshi S,
Mitsudomi T and Takahashi T: Reduced expression of Dicer associated
with poor prognosis in lung cancer patients. Cancer Sci.
96:111–115. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Meng F, Henson R, Lang M, Wehbe H,
Maheshwari S, Mendell JT, Jiang J, Schmittgen TD and Patel T:
Involvement of human micro-RNA in growth and response to
chemotherapy in human cholangiocarcinoma cell lines.
Gastroenterology. 130:2113–2129. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yang N, Kaur S, Volinia S, et al: MicroRNA
microarray identifies Let-7i as a novel biomarker and therapeutic
target in human epithelial ovarian cancer. Cancer Res.
68:10307–10314. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lawrie CH, Gal S, Dunlop HM, Pushkaran B,
Liggins AP, Pulford K, Banham AH, Pezzella F, Boultwood J,
Wainscoat JS, Hatton CS and Harris AL: Detection of elevated levels
of tumour-associated microRNAs in serum of patients with diffuse
large B-cell lymphoma. Br J Haematol. 141:672–675. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mitchell PS, Parkin RK, Kroh EM, et al:
Circulating microRNAs as stable blood-based markers for cancer
detection. Proc Natl Acad Sci USA. 105:10513–10518. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Krützfeldt J, Kuwajima S, Braich R, Rajeev
KG, Pena J, Tuschl T, Manoharan M and Stoffel M: Specificity,
duplex degradation and subcellular localization of antagomirs.
Nucleic Acids Res. 35:2885–2892. 2007.PubMed/NCBI
|
|
14
|
Esau C, Davis S, Murray SF, et al: miR-122
regulation of lipid metabolism revealed by in vivo antisense
targeting. Cell Metab. 3:87–98. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Galardi S, Mercatelli N, Giorda E,
Massalini S, Frajese GV, Ciafrè SA and Farace MG: miR-221 and
miR-222 expression affects the proliferation potential of human
prostate carcinoma cell lines by targeting p27Kip1. J Biol Chem.
282:23716–23724. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Welch C, Chen Y and Stallings RL:
MicroRNA-34a functions as a potential tumor suppressor by inducing
apoptosis in neuroblastoma cells. Oncogene. 26:5017–5022. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Pan Q and Chegini N: MicroRNA signature
and regulatory functions in the endometrium during normal and
disease states. Semin Reprod Med. 26:479–493. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Boren T, Xiong Y, Hakam A, Wenham R, Apte
S, Wei Z, Kamath S, Chen DT, Dressman H and Lancaster JM: MicroRNAs
and their target messenger RNAs associated with endometrial
carcinogenesis. Gynecol Oncol. 110:206–215. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Myatt SS, Wang J, Monteiro LJ, Christian
M, Ho KK, Fusi L, Dina RE, Brosens JJ, Ghaem-Maghami S and Lam EW:
Definition of microRNAs that repress expression of the tumor
suppressor gene FOXO1 in endometrial cancer. Cancer Res.
70:367–377. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hiroki E, Akahira J, Suzuki F, Nagase S,
Ito K, Suzuki T, Sasano H and Yaegashi N: Changes in microRNA
expression levels correlate with clinicopathological features and
prognoses in endometrial serous adenocarcinomas. Cancer Sci.
101:241–249. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chung TK, Cheung TH, Huen NY, et al:
Dysregulated microRNAs and their predicted targets associated with
endometrioid endometrial adenocarcinoma in Hong Kong women. Int J
Cancer. 124:1358–1365. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Osaki M, Takeshita F and Ochiya T:
MicroRNAs as biomarker and therapeutic drugs in human cancer.
Biomarkers. 13:658–670. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tanaka M, Oikawa K, Takanashi M, Kudo M,
Ohyashiki J, Ohyashiki K and Kuroda M: Down-regulation of miR-92 in
human plasma is a novel marker for acute leukemia patients. PLoS
One. 4:e55322009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wu W, Lin Z, Zhang Z and Liang X:
Expression profile of mammalian microRNAs in endometrial carcinoma.
Eur J Cancer Prev. 18:50–55. 2009. View Article : Google Scholar
|
